Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 281

1.

CNS delivery of vectored prion-specific single-chain antibodies delays disease onset.

Wuertzer CA, Sullivan MA, Qiu X, Federoff HJ.

Mol Ther. 2008 Mar;16(3):481-6. doi: 10.1038/sj.mt.6300387. Epub 2008 Jan 8.

PMID:
18180775
[PubMed - indexed for MEDLINE]
2.

Development of antibody fragments for immunotherapy of prion diseases.

Campana V, Zentilin L, Mirabile I, Kranjc A, Casanova P, Giacca M, Prusiner SB, Legname G, Zurzolo C.

Biochem J. 2009 Mar 15;418(3):507-15. doi: 10.1042/BJ20081541.

PMID:
19000036
[PubMed - indexed for MEDLINE]
Free Article
3.

Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy.

Zuber C, Mitteregger G, Schuhmann N, Rey C, Knackmuss S, Rupprecht W, Reusch U, Pace C, Little M, Kretzschmar HA, Hallek M, Büning H, Weiss S.

J Gen Virol. 2008 Aug;89(Pt 8):2055-61. doi: 10.1099/vir.0.83670-0.

PMID:
18632978
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases.

Zuber C, Knackmuss S, Rey C, Reusch U, Röttgen P, Fröhlich T, Arnold GJ, Pace C, Mitteregger G, Kretzschmar HA, Little M, Weiss S.

Mol Immunol. 2008 Jan;45(1):144-51. Epub 2007 Jun 18.

PMID:
17576014
[PubMed - indexed for MEDLINE]
6.

Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.

Miyamoto K, Kimura S, Nakamura N, Yokoyama T, Horiuchi H, Furusawa S, Matsuda H.

Biologicals. 2007 Oct;35(4):303-8. Epub 2007 Mar 23.

PMID:
17363268
[PubMed - indexed for MEDLINE]
7.

Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.

Kupfer L, Eiden M, Buschmann A, Groschup MH.

Biochim Biophys Acta. 2007 Jun;1772(6):704-13. Epub 2006 Oct 18.

PMID:
17145171
[PubMed - indexed for MEDLINE]
Free Article
8.

Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants.

Harmeyer S, Pfaff E, Groschup MH.

J Gen Virol. 1998 Apr;79 ( Pt 4):937-45.

PMID:
9568991
[PubMed - indexed for MEDLINE]
Free Article
9.

Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.

Cardinale A, Filesi I, Vetrugno V, Pocchiari M, Sy MS, Biocca S.

J Biol Chem. 2005 Jan 7;280(1):685-94. Epub 2004 Oct 28.

PMID:
15513919
[PubMed - indexed for MEDLINE]
Free Article
10.

Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.

Nikles D, Bach P, Boller K, Merten CA, Montrasio F, Heppner FL, Aguzzi A, Cichutek K, Kalinke U, Buchholz CJ.

J Virol. 2005 Apr;79(7):4033-42.

PMID:
15767405
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Generation of genuine prion infectivity by serial PMCA.

Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, Kretzschmar HA.

Vet Microbiol. 2007 Aug 31;123(4):346-57. Epub 2007 Apr 7.

PMID:
17493773
[PubMed - indexed for MEDLINE]
12.

Packaging of prions into exosomes is associated with a novel pathway of PrP processing.

Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF.

J Pathol. 2007 Apr;211(5):582-90.

PMID:
17334982
[PubMed - indexed for MEDLINE]
13.

Anti-prion antibodies for prophylaxis following prion exposure in mice.

Sigurdsson EM, Sy MS, Li R, Scholtzova H, Kascsak RJ, Kascsak R, Carp R, Meeker HC, Frangione B, Wisniewski T.

Neurosci Lett. 2003 Jan 23;336(3):185-7.

PMID:
12505623
[PubMed - indexed for MEDLINE]
14.

Prion diseases and emerging prion diseases.

Yokoyama T, Mohri S.

Curr Med Chem. 2008;15(9):912-6. Review.

PMID:
18473798
[PubMed - indexed for MEDLINE]
15.

The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.

Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, Hafner-Bratkovic I, Jerala R, Hornemann S, Wuthrich K, Bellon A, Vey M, Garen G, James MN, Kav N, Aguzzi A.

PLoS One. 2008;3(12):e3872. doi: 10.1371/journal.pone.0003872. Epub 2008 Dec 8.

PMID:
19060956
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.

Määttänen P, Taschuk R, Ross L, Marciniuk K, Bertram L, Potter A, Cashman NR, Napper S.

Prion. 2013 Sep-Oct;7(5):434-9. doi: 10.4161/pri.26639. Epub 2013 Oct 8.

PMID:
24105298
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.

Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, Bertsch U, Kretzschmar H.

J Clin Invest. 2006 Dec;116(12):3204-10.

PMID:
17143329
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prion-protein-specific aptamer reduces PrPSc formation.

Proske D, Gilch S, Wopfner F, Schätzl HM, Winnacker EL, Famulok M.

Chembiochem. 2002 Aug 2;3(8):717-25.

PMID:
12203970
[PubMed - indexed for MEDLINE]
19.

Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.

Dong CF, Wang XF, Wang X, Shi S, Wang GR, Shan B, An R, Li XL, Zhang BY, Han J, Dong XP.

Med Microbiol Immunol. 2008 Dec;197(4):361-8. Epub 2007 Dec 18.

PMID:
18087720
[PubMed - indexed for MEDLINE]
20.

Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice.

Sacquin A, Chaigneau T, Defaweux V, Adam M, Schneider B, Bruley Rosset M, Eloit M.

Brain Behav Immun. 2012 Aug;26(6):919-30. doi: 10.1016/j.bbi.2012.04.002. Epub 2012 Apr 13.

PMID:
22522067
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk